國立虎尾科技大學 |

Nanotechnology-COVID-19 Interface

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Nanotechnology-COVID-19 Interface/ by Devasena T.
Author:	T., Devasena.
Description:	VIII, 142 p. 12 illus.online resource. :
Contained By:	Springer Nature eBook
Subject:	Biophysics. -
Online resource:	https://doi.org/10.1007/978-981-33-6300-7
ISBN:	9789813363007

Nanotechnology-COVID-19 Interface
T., Devasena.

Nanotechnology-COVID-19 Interface[electronic resource] /by Devasena T. - 1st ed. 2021. - VIII, 142 p. 12 illus.online resource. - Nanotheranostics,2197-6759. - Nanotheranostics,.

1. introduction to COVID-19 -- 2. STRUCTURE OF SARS COV2 -- 3. TROPISM OF SARS COV2 -- 4. NANOTECHNOLOGY-COVID 19 INTERFACE -- 5. NANOPARTICLES IN DIAGNOSIS OF COVID-19.

This book highlights the role of nanotechnology concepts in the management of COVID-19 pandemic. The book covers different aspects of the causative agent SARS CoV2 (Severe Acute Respiratory Syndrome Coronavirus-2) and the COVID-19 pandemic with a special emphasis on nanotechnology. It discusses the origin and history of SARS CoV2 and the outbreak of COVID-19 and highlights the geographical mutations in the SARS CoV2 virus genome, providing information about the structural features, antigenicity and the life cycle of SARS CoV2. The book provides an insight into nanotechnology–virology interface and explains how nanomaterials link the gap between the vital phases of SARS CoV2 life cycle and the four modalities of COVID-19 management viz sensing/diagnosis, therapy, prevention and self-protection. Further, the existing and promising diagnostic tools for detection of COVID-19 are discussed with an emphasis on nano PCR, nanoimmunosensors, biobarcode assay and point of care approach and also describe the nanoparticles involved in the CT imaging of lungs and SFHI (Spatial Frequency Hetrodyne Imaging) for diagnosis of SARS COV2 infection. The book concludes with details about translational medicine and explains the types of SARS CoV2 vaccines, stages of COVID-19 vaccine development and possible nanovaccines for COVID-19, followed by the description on biopharmaceutical companies involved in the production of SARS CoV2 vaccines.

ISBN: 9789813363007

Standard No.: 10.1007/978-981-33-6300-7doiSubjects--Topical Terms:

581576
Biophysics.

LC Class. No.: QH505

Dewey Class. No.: 571.4

Nanotechnology-COVID-19 Interface
LDR:02932nam a22004095i 4500 001 1052786
003 DE-He213
005 20210922012318.0
007 cr nn 008mamaa
008 220103s2021 si | s |||| 0|eng d
020 $a 9789813363007 $9 978-981-33-6300-7
024 7 $a 10.1007/978-981-33-6300-7 $2 doi
035 $a 978-981-33-6300-7
050 4 $a QH505
072 7 $a PHVN $2 bicssc
072 7 $a SCI009000 $2 bisacsh
072 7 $a PHVN $2 thema
072 7 $a PHVD $2 thema
082 0 4 $a 571.4 $2 23
100 1 $a T., Devasena. $e author. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1357550
245 1 0 $a Nanotechnology-COVID-19 Interface $h [electronic resource] / $c by Devasena T.
250 $a 1st ed. 2021.
264 1 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2021.
300 $a VIII, 142 p. 12 illus. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Nanotheranostics, $x 2197-6759
505 0 $a 1. introduction to COVID-19 -- 2. STRUCTURE OF SARS COV2 -- 3. TROPISM OF SARS COV2 -- 4. NANOTECHNOLOGY-COVID 19 INTERFACE -- 5. NANOPARTICLES IN DIAGNOSIS OF COVID-19.
520 $a This book highlights the role of nanotechnology concepts in the management of COVID-19 pandemic. The book covers different aspects of the causative agent SARS CoV2 (Severe Acute Respiratory Syndrome Coronavirus-2) and the COVID-19 pandemic with a special emphasis on nanotechnology. It discusses the origin and history of SARS CoV2 and the outbreak of COVID-19 and highlights the geographical mutations in the SARS CoV2 virus genome, providing information about the structural features, antigenicity and the life cycle of SARS CoV2. The book provides an insight into nanotechnology–virology interface and explains how nanomaterials link the gap between the vital phases of SARS CoV2 life cycle and the four modalities of COVID-19 management viz sensing/diagnosis, therapy, prevention and self-protection. Further, the existing and promising diagnostic tools for detection of COVID-19 are discussed with an emphasis on nano PCR, nanoimmunosensors, biobarcode assay and point of care approach and also describe the nanoparticles involved in the CT imaging of lungs and SFHI (Spatial Frequency Hetrodyne Imaging) for diagnosis of SARS COV2 infection. The book concludes with details about translational medicine and explains the types of SARS CoV2 vaccines, stages of COVID-19 vaccine development and possible nanovaccines for COVID-19, followed by the description on biopharmaceutical companies involved in the production of SARS CoV2 vaccines.
650 0 $a Biophysics. $3 581576
650 0 $a Biological physics. $3 1253579
650 0 $a Nanotechnology. $3 557660
650 0 $a Chemistry. $3 593913
650 0 $a Biotechnology. $3 554955
650 0 $a Biomaterials. $3 677000
650 0 $a Sociology. $3 551705
650 1 4 $a Biological and Medical Physics, Biophysics. $3 1113305
650 2 4 $a Nanotechnology and Microengineering. $3 722030
650 2 4 $a Chemistry/Food Science, general. $3 593890
650 2 4 $a Sociology, general. $3 882446
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9789813362994
776 0 8 $i Printed edition: $z 9789813363014
830 0 $a Nanotheranostics, $x 2197-6740 $3 1264911
856 4 0 $u https://doi.org/10.1007/978-981-33-6300-7
912 $a ZDB-2-PHA
912 $a ZDB-2-SXP
950 $a Physics and Astronomy (SpringerNature-11651)
950 $a Physics and Astronomy (R0) (SpringerNature-43715)